about
Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndromeKeratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repairReceptor for advanced glycation end-products is a marker of type I cell injury in acute lung injuryPlasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome.Gender and acute respiratory distress syndrome in critically injured adults: a prospective study.Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure.Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury.Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injuryPlasma biomarkers of oxidant stress and development of organ failure in severe sepsis.Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injuryRatio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients.Laminin gamma2 fragments are increased in the circulation of patients with early phase acute lung injury.Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation.Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.Circulating microparticle levels are reduced in patients with ARDS.Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial.Association between haptoglobin, hemopexin and mortality in adults with sepsisBiomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome.The needle in the haystack: searching for biomarkers in acute respiratory distress syndrome.Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis.Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.Beyond mortality: future clinical research in acute lung injury.Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomesThe association between BMI and plasma cytokine levels in patients with acute lung injury.Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension.Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma.The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.Construct validity of the definition of primary graft dysfunction after lung transplantation.Alveolar fluid clearance is faster in women with acute lung injury compared to men.Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages.Case of fulminant hepatic failure due to unrecognized peripartum cardiomyopathy.Genomics and proteomics of lung disease: conference summary.MCP-1 gene activation marks acute kidney injuryHeterogeneous phenotypes of acute respiratory distress syndrome after major trauma.Clinical practice. Acute pulmonary edema.Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation.Elevation of plasma cell-free hemoglobin in pulmonary arterial hypertensionApproach to the patient with the acute respiratory distress syndrome.Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury.
P50
Q24685217-A3AE1E51-C43A-4E14-B70C-5B6D4A1D82BBQ28214201-6E378C98-4A26-41B3-BF68-180ABAE3E13CQ28566123-D655AC82-5828-4023-B1FC-4E029DE341E4Q30360456-41A87875-D9BB-4DE3-B5BD-CA564A7C461BQ30424763-85779959-EB24-4F91-A605-EA7D42C5CFD3Q30826105-FA3F4339-7EA7-4D3A-86A1-FE1BDA651C23Q33183912-9F2296B5-80BC-46C6-BB79-4E6F541F02BEQ33197095-7240E46B-2348-4FC0-8FE4-9E6EC81CAC73Q33356631-0882CCB4-F095-441A-B91B-55C8B97CC306Q33394380-A521323F-9AFD-4AFD-8F87-6AD67A2DCDD5Q33512670-15FBA967-F350-43A8-99B2-03739664C60FQ33564598-1CD265E6-0896-466D-947B-67C10A53F1A7Q33646134-01567CB9-F1D6-4A05-8E2C-3E611F278BC8Q33650349-495275E9-DC25-4FFA-A9D7-4057D7782184Q33714045-AB3C3F34-509F-4183-830C-0C6C24FB3E56Q33730684-76D994C6-A3D8-446E-BCC3-285C68CD949EQ33745478-1D7DC995-F2E6-4AF3-B27F-ADF51102CF79Q33750778-0B1A6FEA-DF40-4C84-9353-9ACBA815432AQ33750995-4362DEA0-8C2A-407D-9B23-31C14D724FEFQ33751893-DCA8856A-A209-4EC9-B423-438A6C4E1AAFQ33752473-F0E2C4BC-96B9-4CD6-9A49-241B51CAAE31Q33808300-AD2F1D2D-C925-4E4C-B3B0-E0B91CEBFD23Q33868624-84385612-A718-4DE4-BF8B-3759F94FCD8DQ34075434-454F0AA7-99F2-4B8D-9AD5-D02BE461BBA7Q34130717-78281BF2-D3B1-465F-A0B2-EFFFE260FC91Q34130859-83A08B8C-FCCA-4E20-B204-83C01A94C02AQ34147463-6E7626D6-3C08-495E-83AA-DF133C459944Q34179896-309E7EA8-09B2-4BEC-A145-2356AFD302CEQ34238666-8D5853CC-85AC-48D5-A915-1173B724DBDFQ34316213-629A9EC8-EF0F-4B1E-A17F-2D459F325D24Q34400787-C6D61639-C26C-44E0-9DA9-272F6B14B61AQ34409790-45E0D152-3B4D-4EA3-A9C8-C2D014147DF7Q34420043-03AE95BE-3C21-4EC3-85A8-EF82860B3671Q34457306-74191AE7-C50B-465F-87EF-24C61979EE5DQ34479261-39AB68F9-ACDA-4AD5-A021-4FDC8AC2297CQ34480278-6D6F4DFF-F8B8-4A3B-B420-8829C6323553Q34532579-FA7226A1-7B18-4A7D-A9A6-6E7A0F90CA00Q34609897-04505BF7-D2E2-4FFB-9DB8-E7124E1B5B99Q34625416-312AC18A-DA4E-4C4C-BF47-9D24539CBDC2Q34695953-2B6E3FC1-6E01-4553-84BA-BEF931A627D1
P50
description
physician and researcher
@en
name
Lorraine B. Ware
@en
Lorraine B. Ware
@nl
type
label
Lorraine B. Ware
@en
Lorraine B. Ware
@nl
prefLabel
Lorraine B. Ware
@en
Lorraine B. Ware
@nl